The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma

Blood

Volumn 92, Issue 8, 1998, Pages 2688-2695

  Wlodarska, Iwona ^a,b   De Wolf Peeters, Chris ^a,b   Falini, Brunangelo ^a,b   Verhoef, Gregor ^a,b   Morris, Stephan W ^a,b   Hagemeijer, Anne ^a,b   Van Berghe, Herman Den ^c,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF PERUGIA   (Italy)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d CENTER FOR HUMAN GENETICS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 2P; CHROMOSOME 5Q; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 2; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 0032532272     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.8.2688.420a42_2688_2695     Document Type: Article

References (32)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JCK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müllier-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
2. Falini B, Pileri S, Pizzolo KG, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85:1, 1995
3. NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
4. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG: Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 87:3860, 1996
5. NPM/ALK. Am J Med Genet 21:1420, 1997
6. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
7. Iwahara T, Fujimoto FJ, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T: Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 14:439, 1997
8. Morris SW, Naeve C, Mathew P, James PL. Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kianse that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 14:2175, 1997
9. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles D (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 698
10. Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC: Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms. Leuk Lymphoma 29:507, 1998
11. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinoshama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
12. Hutchison RE, Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW: Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Ann Oncol 8:537, 1997 (suppl 1)
13. Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY: Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89:1394, 1997
14. Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C: The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 151:343, 1997
15. Pileri SA, Mason DY, Mori S, Pulford K, Sabattini E, Roncador G, Piccaluga PP, Stein H, Falini B: Frequent expression of the p80 NPM-ALK chimeric fusion protein in anaplastic large cell lymphoma, lympho-histiocytic type. Am J Pathol 150:1207, 1997
16. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugières L, Terrier-Lacombe M-J, Haralambieva E, Pulford K, Pileri S, Morris SW, Mason DY, Delsol G: ALK-positive lymphoma: A single disease with a broad spectrum of morphology. Blood 91:2076, 1998
17. Falini B, Bigerna B, Fizzotti M, Pulford K, Pileri S, Delsol G, Carbone A, Paulli M, Magrini U, Menestrina F, Giardini R, Pilotti S, Mezzelani A, Ugolini B, Billi M, Pucciarini A, Pacini R, Pelicci PG, Flenghi L: ALK expression defines a distinct group of T/Null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol (in press)
18. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni C, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martilli MF, Pelicci PG, Dalla Favera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 148:1543, 1996
19. Pileri S, Rokncador G, Ceccarrelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 183:116, 1997
20. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
21. Mitelman F (ed): ISCN: Guidelines for Cancer Cytogenetics. Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
22. Dierlamm J, Wlodarska I, Michaux L, La Starza R, Zeller W, Mecucci C, Van den Berghe H: Successful use of the same slide for consecutive fluorescence in situ hybridization (FISH) experiments. Genes Chromosom Cancer 16:261, 1996
23. Mathew P, Sanger WG, Weisenburger DD, Valentine M,. Valentine V, Pickering D, Higgins C, Hess M, Cui X, Srivastava DK, Morris SW: Detection of the t(2;5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization. Blood 89:1678, 1997
24. Chumakov IM, Rigault P, Le Gall I, Bellanne-Chantelot C, Billault A, Guillou S, Soularue P, Guasconi G, Poullier E, Gros I, Belova M, Sambucy J-L, Susini L, Gervy P, Gilbert F, Beaufils S, Bui H, Massart C, De Tand M-F, Dukasz F, Lecoulant S, Ougen P, Perrot V, Saumier M, Soravito C, Bahouayila R, Cohen-Akenine A, Barillot E, Bertrand S, Codani J-J, Caterina D, Georges I, Lacroix B, Lucotte G, Sahbatou M, Schmit C, Sangouard M, Tubacher E, Dib C, Fauré S, Fizames C, Gyapay G, Millasseau P, Nguyen S, Muselet D, Vignal A, Morissette J, Menninger J, Lieman J, Desai T, Banks A, Bray-Ward P, Ward D, Hudson T, Gerety S, Foote S, Stein L, Page DC, Lander ES, Weissenbuch J, Le Paslier D, Cohen D: A YAC contig map of the human genome. Nature 377:175, 1995
25. Geier SJ, Algate PA, Carlberg K, Flowers D, Friedman C, Trask B, Rohrschneider LR: The human SHIP gene is differentially expressed in cell lineages of the bone marrow and blood. Blood 89:1876, 1997
26. National Institutes of Health and Institute of Molecular Medicine Collaboration: A complete set of human telomeric probes and their clinical application. Nat Genet 14:86, 1996
27. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
28. Mecucci C, Van den Berghe H: Cytogenetics, in Hematol Oncol Clin North Am 6:523, 1992
29. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T: Characterization of the transforming activity of p80 a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 93:4181, 1996
30. Bischof D, Pulford K, Mason DY, Morris SW: Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol 17:2312, 1997
31. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW: Retrovirus-mediated gene transfer of NPMALK causes lymphoid malignancy in mice. Blood 90:2901, 1997
32. Mason DY, Pulford KAF, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G, Morris SW: Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res 58:1057, 1998